361 related articles for article (PubMed ID: 30930091)
1. Central GLP-1 receptors: Novel molecular targets for cocaine use disorder.
Hernandez NS; Schmidt HD
Physiol Behav; 2019 Jul; 206():93-105. PubMed ID: 30930091
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-Like Peptide-1 Receptor Activation in the Ventral Tegmental Area Decreases the Reinforcing Efficacy of Cocaine.
Schmidt HD; Mietlicki-Baase EG; Ige KY; Maurer JJ; Reiner DJ; Zimmer DJ; Van Nest DS; Guercio LA; Wimmer ME; Olivos DR; De Jonghe BC; Hayes MR
Neuropsychopharmacology; 2016 Jun; 41(7):1917-28. PubMed ID: 26675243
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats.
Hernandez NS; Ige KY; Mietlicki-Baase EG; Molina-Castro GC; Turner CA; Hayes MR; Schmidt HD
Neuropsychopharmacology; 2018 Sep; 43(10):2000-2008. PubMed ID: 29497166
[TBL] [Abstract][Full Text] [Related]
4. Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats.
Zhang Y; Kahng MW; Elkind JA; Weir VR; Hernandez NS; Stein LM; Schmidt HD
Neuropsychopharmacology; 2020 Feb; 45(3):451-461. PubMed ID: 31581176
[TBL] [Abstract][Full Text] [Related]
5. GLP-1 receptor signaling in the laterodorsal tegmental nucleus attenuates cocaine seeking by activating GABAergic circuits that project to the VTA.
Hernandez NS; Weir VR; Ragnini K; Merkel R; Zhang Y; Mace K; Rich MT; Christopher Pierce R; Schmidt HD
Mol Psychiatry; 2021 Aug; 26(8):4394-4408. PubMed ID: 33257815
[TBL] [Abstract][Full Text] [Related]
6. Possible Mechanisms Underlying the Effects of Glucagon-Like Peptide-1 Receptor Agonist on Cocaine Use Disorder.
Zhu C; Li H; Kong X; Wang Y; Sun T; Wang F
Front Pharmacol; 2022; 13():819470. PubMed ID: 35300299
[TBL] [Abstract][Full Text] [Related]
7. Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1.
Jerlhag E
Brain Res; 2020 Jan; 1727():146562. PubMed ID: 31759971
[TBL] [Abstract][Full Text] [Related]
8. A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats.
Zhang Y; Rahematpura S; Ragnini KH; Moreno A; Stecyk KS; Kahng MW; Milliken BT; Hayes MR; Doyle RP; Schmidt HD
Neuropharmacology; 2021 Jul; 192():108599. PubMed ID: 33965397
[TBL] [Abstract][Full Text] [Related]
9. A novel approach to treating opioid use disorders: Dual agonists of glucagon-like peptide-1 receptors and neuropeptide Y
Merkel R; Moreno A; Zhang Y; Herman R; Ben Nathan J; Zeb S; Rahematpura S; Stecyk K; Milliken BT; Hayes MR; Doyle RP; Schmidt HD
Neurosci Biobehav Rev; 2021 Dec; 131():1169-1179. PubMed ID: 34715149
[TBL] [Abstract][Full Text] [Related]
10. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice.
Sørensen G; Reddy IA; Weikop P; Graham DL; Stanwood GD; Wortwein G; Galli A; Fink-Jensen A
Physiol Behav; 2015 Oct; 149():262-8. PubMed ID: 26072178
[TBL] [Abstract][Full Text] [Related]
11. Effects of GABA(B) receptor agents on cocaine priming, discrete contextual cue and food induced relapses.
Filip M; Frankowska M
Eur J Pharmacol; 2007 Oct; 571(2-3):166-73. PubMed ID: 17610868
[TBL] [Abstract][Full Text] [Related]
12. Synaptic mechanisms underlying persistent cocaine craving.
Wolf ME
Nat Rev Neurosci; 2016 Jun; 17(6):351-65. PubMed ID: 27150400
[TBL] [Abstract][Full Text] [Related]
13. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.
Xi ZX; Newman AH; Gilbert JG; Pak AC; Peng XQ; Ashby CR; Gitajn L; Gardner EL
Neuropsychopharmacology; 2006 Jul; 31(7):1393-405. PubMed ID: 16205781
[TBL] [Abstract][Full Text] [Related]
14. Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.
Edwards S; Whisler KN; Fuller DC; Orsulak PJ; Self DW
Neuropsychopharmacology; 2007 Feb; 32(2):354-66. PubMed ID: 16541082
[TBL] [Abstract][Full Text] [Related]
15. Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior.
Harasta AE; Power JM; von Jonquieres G; Karl T; Drucker DJ; Housley GD; Schneider M; Klugmann M
Neuropsychopharmacology; 2015 Jul; 40(8):1969-78. PubMed ID: 25669605
[TBL] [Abstract][Full Text] [Related]
16. Activation of glucagon-like peptide-1 receptors in the nucleus accumbens attenuates cocaine seeking in rats.
Hernandez NS; O'Donovan B; Ortinski PI; Schmidt HD
Addict Biol; 2019 Mar; 24(2):170-181. PubMed ID: 29226617
[TBL] [Abstract][Full Text] [Related]
17. Activation of central neurokinin-1 receptors induces reinstatement of cocaine-seeking behavior.
Placenza FM; Vaccarino FJ; Fletcher PJ; Erb S
Neurosci Lett; 2005 Dec; 390(1):42-7. PubMed ID: 16125318
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of mGlu5 R and ΜOPr by priming- and cue-induced reinstatement of cocaine-seeking behaviour in mice.
Georgiou P; Zanos P; Ehteramyan M; Hourani S; Kitchen I; Maldonado R; Bailey A
Addict Biol; 2015 Sep; 20(5):902-12. PubMed ID: 25522112
[TBL] [Abstract][Full Text] [Related]
19. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
Graham DL; Hoppenot R; Hendryx A; Self DW
Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
[TBL] [Abstract][Full Text] [Related]
20. Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder.
Angarita GA; Matuskey D; Pittman B; Costeines JL; Potenza MN; Jastreboff AM; Schmidt HD; Malison RT
Drug Alcohol Depend; 2021 Apr; 221():108614. PubMed ID: 33621809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
